CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Loading organization profile…

Anonymous aggregate analytics use the connection IP transiently only to derive country; the IP is not stored in analytics data. DNT and GPC are honored, with 90-day retention. IP Geolocation by DB-IP.

Institut Pascal - Medical Cannabis Research Engine

CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Organizations/facility

facility organization

Institut Pascal

FR

OPENALEX: I169645620↗ROR: 03vgfxd91↗

People

Connected researchers

Catherine LaporteORCID 0000-0001-9890-489X Frédéric FortinORCID 0000-0002-4078-9523 Georges BrousseORCID 0000-0002-6514-5388 Paulo Rossi MenezesORCID 0000-0001-6330-3314 Pierre michel LlorcaORCID 0000-0001-7438-8990

Public evidence

4 connected articles

Cannabis use as a potential mediator between childhood adversity and first-episode psychosis: results from the EU-GEI case-control study.2023 · Europe PMC Cannabis Use in Physicians: A Systematic Review and Meta-Analysis2023 · PubMed Central Open Access Daily use of high-potency cannabis is associated with more positive symptoms in first-episode psychosis patients: the EU-GEI case-control study.2021 · PubMed Central Open Access The continuity of effect of schizophrenia polygenic risk score and patterns of cannabis use on transdiagnostic symptom dimensions at first-episode psychosis: findings from the EU-GEI study.2021 · PubMed Central Open Access

Matched by exact identifiers only. Profile data: OpenAlex.